関連する実験動画
Updated: May 2, 2026

11:09
Clarifying and Imaging Candida albicans Biofilms
Published on: March 6, 2020
13.1K
コニジオボロマイコシス: 明らかに見過ごされています. 2つの事件に関する報告書
Kulasinghe Arachchige Chethana Charitha Pemasiri1,2, Buddhika Ushani Manukulasooriya3, Amal T G Fernanado4
1Medical Research Institute, Colombo 08, Sri Lanka. chethanap@kln.ac.lk.
BMC infectious diseases
|February 17, 2026
まとめ
コニジオボロマイコシス (Conidiobolomycosis) は,希少な真菌感染症であり,サイの顔の腫れとして現れており,しばしば誤診されます. 早期発見とイトラコナゾールによる抗真菌治療により,2人の患者が完全に回復した.
科学分野:
- ミコロジー菌類学
- 感染症 感染症は感染症です.
- 皮膚科 皮膚科について
背景:
- コニディオボロマイコシス (Conidiobolomycosis) は,希少で慢性的な皮膚下真菌感染症である.
- 主にコニディオボルス・コロナタスとコニディオボルス・インコングルースによって引き起こされる.
- 免疫力のある個人に影響し,ゆっくり進行するサイの顔の腫れとして表され,しばしば誤診されます.
研究 の 目的:
- コニジオボロマイコシスの2件の治療に成功した症例を報告する.
- 早期発見と標的型抗真菌治療の重要性を強調する.
主な方法:
- rino-facialの腫れを持つ2人の免疫能力のある患者は,臨床検査,組織病理学的分析,および微生物学的確認を受けました.
- 治療は,経口イトラコナゾールと飽和したヨウ素カリウム溶液によるものでした.
主要な成果:
- 両方の患者は,医学的管理で症状の完全な解消を達成しました.
- 組織病理学では,粒状炎症を伴う広範な,無菌のキノコヒフェが明らかにされました.
- イトラコナゾールによる治療は,両方の症例において効果的であった.
結論:
- コニディオボロマイコシスは,特に流行地域における,持続的なサイ顔の腫れを持つ患者で考慮されるべきです.
- 早期診断と適時な抗真菌治療は,合併症や変形を予防するために不可欠です.
- 予後は一般的に良好ですが,長期の治療が必要になる場合があります.
関連する概念動画
Skin Diseases and Disorders
5.4K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.4K
Pulmonary Tuberculosis II
2.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.5K
Pulmonary Tuberculosis III
1.8K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.8K
Fungal Group Zygomycota
2.1K
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
2.1K
Fungal Phylum Microsporidia
782
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
782
Antifungal Agents
119
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
119
